ReviewDrugs2026

Recaticimab: The First Fc-Engineered PCSK9 Monoclonal Antibody for More Long-Lasting Effect in Lipid Lowering.

Sha Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.